明德生物
(002932)
| 流通市值：28.75亿 | | | 总市值：42.83亿 |
| 流通股本：1.56亿 | | | 总股本：2.33亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 183,864,439.57 | 232,965,834.91 | 352,691,446.01 | 493,911,960.04 |
| 交易性金融资产 | 404,915,066.68 | 171,465,870.21 | 64,115,416.35 | 64,115,416.35 |
| 应收票据及应收账款 | 652,718,092.06 | 718,781,156.98 | 714,286,789.61 | 764,653,472.04 |
| 其中：应收票据 | 207,853.4 | 143,282.91 | - | 212,057.7 |
| 应收账款 | 652,510,238.66 | 718,637,874.07 | 714,286,789.61 | 764,441,414.34 |
| 应收款项融资 | - | - | - | 2,298,274 |
| 预付款项 | 54,510,061.08 | 60,236,768.75 | 58,914,503.09 | 49,040,683.23 |
| 其他应收款合计 | 17,813,402.86 | 6,385,878.5 | 11,487,110.89 | 6,608,204.3 |
| 存货 | 101,353,434.32 | 81,884,907.26 | 76,064,673.86 | 82,298,479.51 |
| 一年内到期的非流动资产 | 3,161,681,555.56 | 3,323,622,277.78 | 2,807,559,097.22 | 738,792,375 |
| 其他流动资产 | 169,554,187.12 | 169,770,690.81 | 221,797,704.24 | 195,951,542.38 |
| 流动资产合计 | 4,746,410,239.25 | 4,765,113,385.2 | 4,306,916,741.27 | 2,397,670,406.85 |
| 非流动资产: | | | | |
| 长期股权投资 | 244,218,811.48 | 248,403,811.48 | 306,106,981.95 | 247,606,981.95 |
| 其他权益工具投资 | 10,000,000 | 10,000,000 | 10,000,000 | 10,000,000 |
| 固定资产 | 554,513,629.95 | 574,595,888.15 | 579,391,901.41 | 592,140,876.69 |
| 在建工程 | 115,433,761.87 | 121,673,300.76 | 148,729,557.84 | 120,787,956.73 |
| 使用权资产 | 6,703,741.08 | 7,386,465.26 | 8,242,504.47 | 8,751,913.62 |
| 无形资产 | 16,612,238.17 | 16,842,642.04 | 17,073,045.91 | 17,303,449.78 |
| 长期待摊费用 | 2,323,243.77 | 2,578,511.34 | 2,833,778.91 | 3,105,493.38 |
| 递延所得税资产 | 216,258,016.87 | 220,090,745.54 | 214,678,342.39 | 216,900,753.86 |
| 其他非流动资产 | 188,683,395.12 | 187,463,106.23 | 905,429,207.48 | 2,978,810,763.04 |
| 非流动资产合计 | 1,354,746,838.31 | 1,389,034,470.8 | 2,192,485,320.36 | 4,195,408,189.05 |
| 资产总计 | 6,101,157,077.56 | 6,154,147,856 | 6,499,402,061.63 | 6,593,078,595.9 |
| 流动负债: | | | | |
| 短期借款 | 3,000,000 | 3,000,000 | 3,000,000 | 3,000,000 |
| 应付票据及应付账款 | 144,762,117.29 | 168,900,983.95 | 248,241,215.03 | 278,113,513.57 |
| 应付账款 | 144,762,117.29 | 168,900,983.95 | 248,241,215.03 | 278,113,513.57 |
| 合同负债 | 35,279,215.09 | 45,011,858.15 | 40,049,058.89 | 37,963,618.82 |
| 应付职工薪酬 | 52,384,455.48 | 56,229,967.94 | 70,182,245.14 | 87,084,064.89 |
| 应交税费 | 5,767,093.53 | 4,225,880.36 | 5,166,659.92 | 8,249,223.74 |
| 其他应付款合计 | 46,375,576.01 | 40,561,086.84 | 43,833,833 | 67,256,648.85 |
| 一年内到期的非流动负债 | 4,296,271.73 | 4,296,271.73 | 4,296,271.73 | 4,296,271.73 |
| 其他流动负债 | 5,634,558.08 | 6,843,786.89 | 6,709,505.02 | 9,893,196.08 |
| 流动负债合计 | 297,499,287.21 | 329,069,835.86 | 421,478,788.73 | 495,856,537.68 |
| 非流动负债: | | | | |
| 租赁负债 | 3,452,886.89 | 4,293,237.88 | 5,526,201.58 | 5,816,561.4 |
| 预计负债 | 217,691.96 | 1,705,620.41 | 1,440,500 | 1,440,500 |
| 递延收益 | 20,866,000 | 20,866,000 | 20,866,000 | 20,866,000 |
| 递延所得税负债 | 51,668,337.18 | 51,668,337.18 | 50,421,556.8 | 50,421,556.8 |
| 非流动负债合计 | 76,204,916.03 | 78,533,195.47 | 78,254,258.38 | 78,544,618.2 |
| 负债合计 | 373,704,203.24 | 407,603,031.33 | 499,733,047.11 | 574,401,155.88 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 232,500,957 | 232,520,957 | 232,520,957 | 232,520,957 |
| 资本公积 | 818,099,532.65 | 818,099,532.65 | 818,099,532.65 | 818,099,532.65 |
| 减:库存股 | 247,957,340 | 247,957,340 | 247,957,340 | 237,954,376.7 |
| 盈余公积 | 630,728,262.08 | 630,728,262.08 | 630,728,262.08 | 630,728,262.08 |
| 未分配利润 | 4,127,757,724.3 | 4,132,339,825.57 | 4,373,734,412.6 | 4,382,997,688.87 |
| 归属于母公司股东权益合计 | 5,561,129,136.03 | 5,565,731,237.3 | 5,807,125,824.33 | 5,826,392,063.9 |
| 少数股东权益 | 166,323,738.29 | 180,813,587.37 | 192,543,190.19 | 192,285,376.12 |
| 股东权益合计 | 5,727,452,874.32 | 5,746,544,824.67 | 5,999,669,014.52 | 6,018,677,440.02 |
| 负债和股东权益合计 | 6,101,157,077.56 | 6,154,147,856 | 6,499,402,061.63 | 6,593,078,595.9 |
| 公告日期 | 2025-10-31 | 2025-08-28 | 2025-04-30 | 2025-04-25 |
| 审计意见(境内) | | | | 标准无保留意见 |